EXPERIENCE WITH DOLUTEGRAVIR IN HIV PATIENTS AT A PUBLIC SECTOR HOSPITAL IN KARACHI, PAKISTAN
Objective: To study the tolerability and efficacy of dolutegravir in naïve and experienced patients, their management and outcome. Study Design: Cross sectional study. Place and Duration of Study: Ruth KM Pfau Civil Hospital, Karachi Pakistan, from Apr 2018 to Apr 2020. Methodology: In this...
Guardado en:
Autores principales: | Farzana Batool, Sohaima Manzoor, Azizullah Khan Dhiloo, Humera Muhammad Ismail, Shah Muhammad Shaikh, Shehla Baqi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Army Medical College Rawalpindi
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6a188763809449787da9884b5a60b12 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers E, et al.
Publicado: (2018) -
Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
por: Zamora FJ, et al.
Publicado: (2019) -
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
por: Adelline Twimukye, et al.
Publicado: (2021) -
Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
por: Isabelle Malet, et al.
Publicado: (2018) -
How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir
por: Atze T. Das, et al.
Publicado: (2018)